Standard BioTools to report Q2 2025 financial results on August 11.
ByAinvest
Monday, Jul 21, 2025 7:06 am ET1min read
LAB--
Investors can participate in the conference call by dialing:
- US domestic callers: (888) 346-3970
- Outside US callers: (412) 902-4297
The live audio of the webcast will be available online on the Investor Relations page of the company's website. The webcast will also be archived and accessible on the Investor Relations page at investors.standardbio.com.
Standard BioTools Inc., a leading provider of next-generation technologies, focuses on helping biomedical researchers develop better medicines faster. The company's proprietary technologies, including SomaScan, mass cytometry, and microfluidics, enable reliable and repeatable insights in health and disease, transforming scientific discoveries into improved patient outcomes.
For more information, visit Standard BioTools' Investor Relations page at investors.standardbio.com or connect with them on social media platforms like X, Facebook®, LinkedIn, and YouTube™.
References:
[1] https://www.stocktitan.net/news/LAB/standard-bio-tools-schedules-second-quarter-earnings-conference-call-mr4qp52zdn2w.html
• Standard BioTools reports Q2 2025 financial results on Aug 11, 2025. • Company will host conference call and webcast at 4:30 p.m. ET. • Dial-in for US domestic callers: 888-346-3970. • Dial-in for outside US callers: 412-902-4297. • Live audio available on company's website. • Webcast will be archived on the Investor Relations page.
Standard BioTools Inc. (NASDAQ: LAB) has scheduled its second quarter 2025 earnings conference call for Monday, August 11, 2025, following the market close. The company will host a conference call and webcast at 4:30 p.m. ET to discuss its financial results and operational progress for the quarter.Investors can participate in the conference call by dialing:
- US domestic callers: (888) 346-3970
- Outside US callers: (412) 902-4297
The live audio of the webcast will be available online on the Investor Relations page of the company's website. The webcast will also be archived and accessible on the Investor Relations page at investors.standardbio.com.
Standard BioTools Inc., a leading provider of next-generation technologies, focuses on helping biomedical researchers develop better medicines faster. The company's proprietary technologies, including SomaScan, mass cytometry, and microfluidics, enable reliable and repeatable insights in health and disease, transforming scientific discoveries into improved patient outcomes.
For more information, visit Standard BioTools' Investor Relations page at investors.standardbio.com or connect with them on social media platforms like X, Facebook®, LinkedIn, and YouTube™.
References:
[1] https://www.stocktitan.net/news/LAB/standard-bio-tools-schedules-second-quarter-earnings-conference-call-mr4qp52zdn2w.html
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet